Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Islet transplantation is a successful β-cell replacement therapy for selected patients with type 1 diabetes mellitus. Although high rates of early insulin independence are achieved routinely, long-term function wanes over time. Intraportal transplantation is associated with procedural risks, requires multiple donors, and does not afford routine biopsy. Stem cell technologies may require potential for retrievability, and graft removal by hepatectomy is impractical. There is a clear clinical need for an alternative, optimized transplantation site. The subcutaneous space is a potential substitute, but transplantation of islets into this site has routinely failed to reverse diabetes. However, an implanted device, which becomes prevascularized before transplantation, may alter this equation. METHODS: Syngeneic mouse islets were transplanted subcutaneously within Sernova Corp's Cell Pouch (CP). All recipients were preimplanted with CPs 4 weeks before diabetes induction and transplantation. After transplantation, recipients were monitored for glycemic control and glucose tolerance. RESULTS: Mouse islets transplanted into the CP routinely restored glycemic control with modest delay and responded well to glucose challenge, comparable to renal subcapsular islet grafts, despite a marginal islet dose, and normoglycemia was maintained until graft explantation. In contrast, islets transplanted subcutaneously alone failed to engraft. Islets within CPs stained positively for insulin, glucagon, and microvessels. CONCLUSIONS: The CP is biocompatible, forms an environment suitable for islet engraftment, and offers a potential alternative to the intraportal site for islet and future stem cell therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Foreign body reaction to biomaterials
Anderson, J. M., Rodriguez, A., & Chang, D. T. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.004 · Cited by 5,138 · cited 1×
“In addition, the lack of porosity minimizes the potential for development of vascularized tissue resulting in potential hypoxia, graft nonfunction and a persistent foreign body reaction at the device tissue interface further hindering oxygen diffusion and glucose sensing.(33,34) To circumvent this phenomenon, several…”
BackgroundInternational trial of the Edmonton protocol for islet transplantation
Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942 · cited 2×
“C, Fluorescent staining (10 ) of a serial section from the transplanted CP, staining positive for insulin (red), glucagon (green), and nuclei.(1) Scale bars represent 100 μm.”
BackgroundSelf-citationOptimal implantation site for pancreatic islet transplantation
Merani, S., Toso, C., Emamaullee, J., & Shapiro, A. M. J. (2008) · British Journal of Surgery · doi:10.1002/bjs.6391 · Cited by 257
Self-citationClinical and Experimental Pancreatic Islet Transplantation to Striated Muscle
Christoffersson, G., Henriksnäs, J., Johansson, L., Rolny, C., Ahlström, H., Caballero-Corbalan, J., Segersvärd, R., Permert, J., Korsgren, O., Carlsson, P.-O., et al. (2010) · Diabetes · doi:10.2337/db10-0205 · Cited by 167
The TheraCyte™ Device Protects against Islet Allograft Rejection in Immunized Hosts
Kumagai-Braesch, M., Jacobson, S., Mori, H., Jia, X., Takahashi, T., Wernerson, A., Flodström-Tullberg, M., & Tibell, A. (2013) · Cell Transplantation · doi:10.3727/096368912x657486 · Cited by 138
Research works printed but not linked: 32
- Harlan, 2009, Current advances and travails in islet transplantation., Diabetes, 58, 2175, 10.2337/db09-0476 · DOI · Paper page
- Pepper, 2013, Revascularization of transplanted pancreatic islets and role of the transplantation site., Clin Dev Immunol, 2013, 352315, 10.1155/2013/352315 · DOI · Paper page
- Plesner, 2011, Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation., J Transplant, 2011, 979527, 10.1155/2011/979527 · DOI · Paper page
- Cheng, 2005, Islet transplantation for diabetic rats through the spleen., Hepatobiliary Pancreat Dis Int, 4, 203
- White, 2000, The risks of total pancreatectomy and splenic islet autotransplantation., Cell Transplant, 9, 19, 10.1177/096368970000900103 · DOI
- Rajab, 2008, Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation., Cell Transplant, 17, 1015, 10.3727/096368908786991533 · DOI
- Pattou, 2010, GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle., N Engl J Med, 363, 1289, 10.1056/NEJMc1004547 · DOI · Paper page
- Echeverri, 2009, Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs., Am J Transplant, 9, 2485, 10.1111/j.1600-6143.2009.02815.x · DOI
- Kakabadze, 2011, Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine., Transpl Int, 24, 175, 10.1111/j.1432-2277.2010.01160.x · DOI
- Kakabadze, 2013, Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment., Am J Transplant, 13, 2550, 10.1111/ajt.12412 · DOI
- Kakabadze, 2012, An isolated venous sac as a novel site for cell therapy in diabetes mellitus., Transplantation, 94, 319, 10.1097/TP.0b013e31825e4a83 · DOI
- Berman, 2009, Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold., Am J Transplant, 9, 91, 10.1111/j.1600-6143.2008.02489.x · DOI · Paper page
- Maffi, 2013, Autologous pancreatic islet transplantation in human bone marrow., Diabetes, 62, 3523, 10.2337/db13-0465 · DOI · Paper page
- Tuch, 2009, Safety and viability of microencapsulated human islets transplanted into diabetic humans., Diabetes Care, 32, 1887, 10.2337/dc09-0744 · DOI · Paper page
- Sakata, 2014, Strategy for clinical setting in intramuscular and subcutaneous islet transplantation., Diabetes Metab Res Rev, 30, 1, 10.1002/dmrr.2463 · DOI · Paper page
- Pileggi, 2006, Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device., Transplantation, 81, 1318, 10.1097/01.tp.0000203858.41105.88 · DOI · Paper page
- Toso, 2010, Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture., Transpl Int, 23, 259, 10.1111/j.1432-2277.2009.00984.x · DOI · Paper page
- Kemp, 1973, Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats., Diabetologia, 9, 486, 10.1007/BF00461694 · DOI · Paper page
- Lacy, 1991, Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets., Science, 254, 1782, 10.1126/science.1763328 · DOI · Paper page
- Juang, 1996, Outcome of subcutaneous islet transplantation improved by polymer device., Transplantation, 61, 1557, 10.1097/00007890-199606150-00001 · DOI · Paper page
- Ludwig, 2012, Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist., Proc Natl Acad Sci U S A, 109, 5022, 10.1073/pnas.1201868109 · DOI · Paper page
- Kim, 2012, In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation., J Control Release, 162, 382, 10.1016/j.jconrel.2012.07.018 · DOI
- Perez-Basterrechea, 2009, Plasma-fibroblast gel as scaffold for islet transplantation., Tissue Eng Part A, 15, 569, 10.1089/ten.tea.2008.0088 · DOI
- Dufrane, 2010, Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression., Transplantation, 90, 1054, 10.1097/TP.0b013e3181f6e267 · DOI · Paper page
- Ludwig, 2013, Transplantation of human islets without immunosuppression., Proc Natl Acad Sci U S A, 110, 19054, 10.1073/pnas.1317561110 · DOI · Paper page
- Sorenby, 2008, Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model., Transplantation, 86, 364, 10.1097/TP.0b013e31817efc78 · DOI · Paper page
- Wilson, 2008, Challenges and emerging technologies in the immunoisolation of cells and tissues., Adv Drug Deliv Rev, 60, 124, 10.1016/j.addr.2007.08.034 · DOI · Paper page
- Sterkers, 2013, Islet survival and function following intramuscular autotransplantation in the minipig., Am J Transplant, 13, 891, 10.1111/ajt.12136 · DOI
- Pileggi, 2001, Factors influencing Islet of Langerhans graft function and monitoring., Clin Chim Acta, 310, 3, 10.1016/S0009-8981(01)00503-4 · DOI
- Bennet, 2000, Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes., Ups J Med Sci, 105, 125, 10.1517/03009734000000059 · DOI · Paper page
- Roep, 1999, Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients., Diabetes, 48, 484, 10.2337/diabetes.48.3.484 · DOI · Paper page
- Jones, 2007, Time course and quantification of pancreatic islet revascularization following intraportal transplantation., Cell Transplant, 16, 505, 10.3727/000000007783464993 · DOI
Cited by
Advances in islet encapsulation technologies
Desai, T., & Shea, L. D. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.232 · Cited by 427
Cell encapsulation: Overcoming barriers in cell transplantation in diabetes and beyond
Farina, M., Alexander, J. F., Thekkedath, U., Ferrari, M., & Grattoni, A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.018 · Cited by 192
The journey of islet cell transplantation and future development
Gamble, A., Pepper, A. R., Bruni, A., & Shapiro, A. M. J. (2018) · Islets · doi:10.1080/19382014.2018.1428511 · Cited by 171
Self-citationModular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets
Vlahos, A. E., Cober, N., & Sefton, M. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619216114 · Cited by 132
Li, G., He, J., Shi, J., Li, X., Liu, L., Ge, X., Chen, W., Jia, J., Wang, J., Yin, M., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333885 · Cited by 41
Metadata
- Authors
- Pepper, A. R., Pawlick, R., Gala-Lopez, B., MacGillivary, A., Mazzuca, D. M., White, D. J. G., Toleikis, P. M., & Shapiro, A. M. J.
- Venue
- Transplantation
- Published
- 2015-11
- Volume
- 99
- Issue
- 11
- Pages
- 2294-2300
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2260094956
- Cited by
- 116
- References
- 5
- FWCI
- 12.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. https://app.cochat.ai/papers/10.1097/tp.0000000000000864
- The paper
- Pepper, A. R., Pawlick, R., Gala-Lopez, B., MacGillivary, A., Mazzuca, D. M., White, D. J. G., Toleikis, P. M., & Shapiro, A. M. J. (2015). Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation. https://doi.org/10.1097/tp.0000000000000864
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.